Oxidative pathways as a drug target for the treatment of autism
Version 2 2024-06-02, 13:07
Version 1 2010-12-01, 00:00
journal contribution
posted on 2024-06-02, 13:07 authored by KA Villagonzalo, Seetal DoddSeetal Dodd, Olivia DeanOlivia Dean, K Gray, B Tonge, Michael BerkMichael BerkOxidative pathways as a drug target for the treatment of autism
History
Related Materials
- 1.
Location
EnglandLanguage
EnglishPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2011, Informa HealthcareJournal
Expert Opinion on Therapeutic TargetsVolume
14Pagination
1301-1310ISSN
1472-8222eISSN
1744-7631Issue
12Publisher
INFORMA HEALTHCAREPublication URL
Usage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicinePharmacology & Pharmacyantioxidant treatmentautismautistic disorderoxidative stressN-ACETYL-CYSTEINEPLACEBO-CONTROLLED TRIALSPECTRUM DISORDERSMITOCHONDRIAL DYSFUNCTIONDOUBLE-BLINDPSYCHIATRIC-DISORDERSGLUTATHIONE PRECURSORMETABOLIC BIOMARKERSALTERNATIVE MEDICINELIPID-PEROXIDATION119999 Medical and Health Sciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC